A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin-Reference-Cited by-同舟云学术

A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin

Published:2010-10 Issue:9 Volume:44 Page:e210-e217
ISSN:0192-0790
Container-title:Journal of Clinical Gastroenterology
language:en
Short-container-title:

Author:

Neri Sergio,Bertino Gaetano,Petralia Antonio,Giancarlo Crisafulli,Rizzotto Agostino,Calvagno Giuseppe Stefano,Mauceri Barbara,Abate Giuseppe,Boemi Patrizia,Di Pino Antonino,Ignaccolo Luca,Vadalà Giuseppe,Misseri Maria,Maiorca Daniela,Mastrosimone Gianluca,Judica Antonino,Palermo Filippo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference33 articles.

1. Review article: pegylated interferons: chemical and clinical differences;Foster;Aliment Pharmacol Ther,2004

2. The clinical spectrum of disease;Hoofnagle;Hepatology,1997

3. 41th Annual meeting; International Consensus Conference on Hepatitis C. Consensus Statement.;J Hepatol,2006

4. A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alpha interferon;Fattovich;J Hepatol,1996

5. Inteferon-induced depression: prevalence and management;Scalori;Digestive Liver Disease,2005

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities;Cell Reports;2021-05

2. Imperfect innate immune antagonism renders SARS-CoV-2 vulnerable towards IFN-γ and -λ;2020-10-15

3. Effects of Direct-Acting Antiviral Agents on the Mental Health of Patients with Chronic Hepatitis C: A Prospective Observational Study;Brain Sciences;2020-07-27

4. Mental Health in Chronic and End-Stage Liver Disease;Psychosocial Care of End-Stage Organ Disease and Transplant Patients;2018-11-23

5. Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions;World Journal of Hepatology;2018-06-27